India, May 29 -- Hyderabad-based Mapmygenome, an artificial intelligence (AI)-driven leader in genomics and personalised health, has announced the strategic acquisition of Microbiome Insights, a global leader in microbial sequencing.

The acquisition includes Microbiome Insights' CAP-accredited Canadian laboratory and rich intellectual property, boosting Mapmygenome's scientific prowess and enabling its global expansion.

Having supported over 600 global clients with 1,000+ cutting-edge microbiome studies, Microbiome Insights is a leading partner for academic, clinical, and industry researchers.

Microbiome Insights will maintain its role as a premier contract research organisation (CRO), empowering global research. Simultaneously, Mapmyg...